Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ITPKB antisense RNA 1 (ITPKB-AS1) is classified as an antisense long noncoding RNA gene located on chromosome 1q. It is annotated in genomic databases (LNCipedia, GeneCards, WikiGenes) as a non-protein-coding RNA transcribed from the opposite strand of the ITPKB protein-coding gene. It possesses at least three transcript isoforms, but no functional studies, disease linkages, or drug interactions have been described so far[1][3][4][13]. There is nothing obviously misspelled about the entry, but "ITPKB antisense RNA 1" is not a standard therapeutic target such as a receptor, enzyme, transporter, or structurally defined RNA with known biological or pharmacological function. The is_target flag is set to false because antisense lncRNAs such as ITPKB-AS1 are generally not the molecule being directly targeted in drug discovery; rather, they are sometimes studied for their potential regulatory roles or biomarker value, which is not described here. The is_incorrect flag is set to true due to missing information, lack of evidence for a defined function, and the molecule not fitting into recognized target classes relevant for therapeutic drug development. If information emerges showing ITPKB-AS1 has a defined function, disease relevance, or druggability, this assessment should be revisited. As of now, it is best categorized as an uncharacterized antisense lncRNA with no evidence for direct druggability or a mechanistic disease role[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ITPKB antisense RNA 1 (ITPKB-AS1).